Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Hundreds of millions of people lack access to affordable and safe medicines. Our biopharma customers are working hard to develop new drugs to improve people's lives.

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry, listed on the German DAX and TecDAX stock markets. In fiscal 2021, the company recorded sales of €3.45 billion, growing by around 49 %.

Our ambition is to simplify progress in biopharmaceutical research and production. We support our customers with innovative technologies that make the development and manufacture of innovative therapeutics faster and more efficient. So that more people have access to better medicine. More than 14,000 employees at over 60 production and sales locations worldwide are committed to this vision.